Malignant Primary Gliomas: Clinical Trials

1 trial for Malignant Primary Gliomas, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Active not recruiting 1

Follow Malignant Primary Gliomas: new trials by email Literature Review of Malignant Primary Gliomas trials Research Report on Malignant Primary Gliomas

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
5G-EMERALD: Amivantamab in Malignant Brain Tumours
Amivantamab - Malignant Primary Gliomas, Glioblastoma Multiform (Grade IV Astrocytoma)
Phase 1Active not recruitingInstitute of Cancer Research, United Kingdom122024-10-092026-08-17

Narrower conditions

Glioblastoma (1)

Broader conditions

Astrocytoma (1)  ·  Glioma (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neoplasms, Neuroepithelial (1)  ·  Neuroectodermal Tumors (1)

Interventions

amivantamab (1)

Sponsors

Institute of Cancer Research, United Kingdom (1)

Countries

United Kingdom (1)

Top investigators

Juanita Lopez, MD, PhD (1)